CU20110123A7 - COCLEATE WITH ONLY MAMP - Google Patents
COCLEATE WITH ONLY MAMPInfo
- Publication number
- CU20110123A7 CU20110123A7 CU2011000123A CU20110123A CU20110123A7 CU 20110123 A7 CU20110123 A7 CU 20110123A7 CU 2011000123 A CU2011000123 A CU 2011000123A CU 20110123 A CU20110123 A CU 20110123A CU 20110123 A7 CU20110123 A7 CU 20110123A7
- Authority
- CU
- Cuba
- Prior art keywords
- veterinary
- adjuvants
- human
- cochlear structures
- antibiotics
- Prior art date
Links
Abstract
La presente invención se relaciona con el campo de la inmunología, específicamente con la rama de los adyuvantes y las vacunas. El objetivo técnico que se persigue es obtener adyuvantes basados en estructuras cocleares no proteolipídicas ni lip´dicas que contengan patrones moleculares asociados a microbios (MAMP) y con la adición opcional de antibióticos/quimioterapéuticos con el fin de emplearlos como Adyuvantes Vacunales para el tratamiento y prevención de enfermedades veterinarias y humanas. Adicionalmente, estos serán empleados como inmunopotenciadores en formulaciones veterinarias y humanas. También es un objetivo técnico de esta patente emplear dichas novedosas estructuras cocleares con antígenos particulares adicionados o liberados in vivo por el efecto combinado de la inmunopotenciación y los antibióticos/quimioterapéuticos en enfermedades infecciosas para la obtención de vacunas terapéuticas veterinarias y humanas en la industria farmacéutica. La invención también se relaciona con el método de obtención de las estructuras cocleares estériles.The present invention relates to the field of immunology, specifically the branch of adjuvants and vaccines. The technical objective is to obtain adjuvants based on non-proteolipid or lipid cochlear structures that contain molecular patterns associated with microbes (MAMP) and with the optional addition of antibiotics / chemotherapeutics in order to use them as Vaccine Adjuvants for the treatment and prevention of veterinary and human diseases. Additionally, these will be used as immunopotentiators in veterinary and human formulations. It is also a technical objective of this patent to employ such novel cochlear structures with particular antigens added or released in vivo by the combined effect of immunopotentiation and antibiotics / chemotherapeutic agents in infectious diseases to obtain veterinary and human therapeutic vaccines in the pharmaceutical industry. The invention also relates to the method of obtaining sterile cochlear structures.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU2011000123A CU20110123A7 (en) | 2011-05-31 | 2011-05-31 | COCLEATE WITH ONLY MAMP |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU2011000123A CU20110123A7 (en) | 2011-05-31 | 2011-05-31 | COCLEATE WITH ONLY MAMP |
Publications (1)
Publication Number | Publication Date |
---|---|
CU20110123A7 true CU20110123A7 (en) | 2013-06-28 |
Family
ID=53838253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU2011000123A CU20110123A7 (en) | 2011-05-31 | 2011-05-31 | COCLEATE WITH ONLY MAMP |
Country Status (1)
Country | Link |
---|---|
CU (1) | CU20110123A7 (en) |
-
2011
- 2011-05-31 CU CU2011000123A patent/CU20110123A7/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2019003264A1 (en) | Formulations for vaccines against neoplasia and methods for preparing the same. (divisional request 201703151) | |
GT201300243A (en) | RAMIFIED 3-PHENYLPROPIONIC ACID DERIVATIVES AND ITS USE | |
CO6630162A2 (en) | 1-amino -2-cyclopropylethylboronic acid derivatives | |
CY1117757T1 (en) | MODIFIED RSV F PROTEINS AND METHODS OF USE | |
ECSP12011834A (en) | Pharmaceutical composition, pharmaceutical dosage form, procedure for its preparation, methods for its treatment and its uses. | |
CU20190101A7 (en) | SUBSTITUTED DIAZABICYCLIC IMIDAZOPYRIMIDINES | |
UY33370A (en) | Pharmaceutical compositions comprising a DPP4 and pioglitazone inhibitor drug, preparation and use procedures | |
PE20151023A1 (en) | TRIAZOLOPYRAZINES | |
CO6400193A2 (en) | DICIANOPIRIDINS ALQUILAMINO-REPLACED AND ITS AMINO ACID ESTER PROPHARMS | |
GT201500025A (en) | PHARMACEUTICAL COMBINATIONS THAT INCLUDE A B-RAF INHIBITOR, AN EGFR INHIBITOR AND OPTIONALLY A PI3K-ALFA INHIBITOR | |
UY33863A (en) | METHODS AND MEDICINES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
BR112015007814A2 (en) | diagnosis, prevention and treatment of joint disease | |
UY32457A (en) | VACCINE OF THE INACTIVATED DENGUE VIRUS | |
BR112015006623A2 (en) | laquinimod and pridopidine for the treatment of neurodegenerative diseases | |
CO6531414A2 (en) | APTAMERS OF THE TISSULAR FACTOR INHIBITOR AND ITS USES AS A TREATMENT OF HEMORRHAGICAL DISORDERS | |
CL2018002692A1 (en) | Bivalent vaccine against swine flu virus (divisional application 201701961) | |
BR112013000776A2 (en) | Method and Formulation for Treatment of Sialic Acid Deficiency | |
BR112014007902A2 (en) | pharmaceutical compositions comprising 40-o- (2-hydroxy) ethyl rapamycin | |
MX2015007753A (en) | Vaccine composition for naive subjects. | |
BR112015018827A2 (en) | oral pharmaceutical composition for oral mucositis and stomatitis treatment | |
CO2017007383A2 (en) | Methods for using antisense oligonucleotides for smad7 | |
UY35091A (en) | MODIFIED RELEASE FORMULATIONS FOR OPROZOMIB | |
CY1118402T1 (en) | USE OF SOURCE L3 AND / OR L5 AS A VACCINE OR AS A DIAGNOSIS FOR DISEASE DISEASE | |
CR20160529A (en) | PHARMACEUTICAL COMPOSITIONS TO TREAT INFECTIOUS DISEASES | |
CR20110226A (en) | COMPOSITION TO TREAT DISEASE |